Bicholim-Goa, India

Jose C J M D S Menezes

This inventor holds 1 USPTO granted patent. Top assignee: Harcros Chemicals, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jose C J M D S Menezes. Retrieved from https://idiyas.com/inventor/jose-c-j-m-d-s-menezes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jose C. J. M. D. S. Menezes and Antimicrobial Innovation.

Introduction

Jose C. J. M. D. S. Menezes is an inventor associated with Bicholim, Goa, India. His patent work concerns compounds and methods for disinfecting and sanitizing.

Latest Patents

Menezes is credited with 1 patent: “Antimicrobial Compounds Based on Glucoheptonic Acids and Their Salts.” The invention describes methods for disinfecting or sanitizing and preparing compounds for those purposes, including glucoheptonic acid, chlorhexidine diglucoheptonate, benzalkonium glucoheptonate, and combinations of these compounds. It also addresses methods for evaluating a compound’s performance in microbial disinfection or sanitization.

Career Highlights

Menezes is associated with Harcros Chemicals, Inc. His patent reflects work on antimicrobial formulations and methods for assessing their potential use as disinfectants or sanitizers.

Collaborations

Peter Radford and Diana Crain are identified as Menezes’s coworkers. The available information does not specify their roles in the patent or the invention.

Conclusion

Jose C. J. M. D. S. Menezes’s patent focuses on antimicrobial compounds and practical methods for preparing and evaluating disinfectants and sanitizers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…